PIGR and cancer: Polymeric immunoglobulin receptor (pIgR) enriched in EVs from HCC cells can promote cancer stemness and aggressiveness by inducing the Akt/ β-catenin axis rather than activating the SMAD2/3 signaling and inducing EMT in HCC cells.